Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Who's the real main character in Shakespearean tragedies? Here's what the data say Martin Grandjean's data visualizations look at the relationships between characters in Shakespearean tragedies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results